The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02188004|
Recruitment Status : Completed
First Posted : July 11, 2014
Last Update Posted : May 7, 2019
primary purpose:Evaluate the prevalence and incidence of HPV infection and related diseases in subjects.
Secondary purpose:Analyze risk factors of HPV infection and related diseases.
|Condition or disease|
|Human Papillomavirus Infection Genital Warts|
|Study Type :||Observational|
|Actual Enrollment :||4691 participants|
|Official Title:||The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases In Male and Female Aged Over 18 Years In China|
|Study Start Date :||June 2014|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||May 2016|
- prevalence and incidence of HPV infection [ Time Frame: 1 year ]Evaluate the prevalence and incidence of HPV infection and related diseases in subjects
- risk factors of HPV infection and related diseases [ Time Frame: 1 year ]Analyze risk factors of HPV infection and related diseases.
Biospecimen Retention: Samples With DNA
Male:Two swabs were used to collect exfoliated skin cells from the coronal sulcus /glans/shaft and anal
Female:Three swabs were used to collect exfoliated skin cells from the vagina，vulva and anal
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02188004
|Liuzhou Center of disease prevention and control|
|Liuzhou, Guangxi, China|
|Study Chair:||Jun Zhang||Xiamen University|
|Principal Investigator:||Ming-Qiang Li||Liuzhou center of disease prevention and control|